Drugs Made In America Acquisition Corp. (DMAAU) Cash from Investing Activities (2025)

Drugs Made In America Acquisition (DMAAU) has 1 years of Cash from Investing Activities data on file, last reported at -$231.2 million in Q1 2025.

• Quarterly Cash from Investing Activities changed N/A year-over-year to -$231.2 million in Q1 2025, while the trailing twelve-month figure through Dec 2025 was -$231.2 million (changed N/A YoY) and the FY2025 annual result came in at -$231.2 million, changed N/A from the prior year.
• Cash from Investing Activities held at -$231.2 million in Q1 2025.
• In the past five years, Cash from Investing Activities ranged from a high of -$231.2 million in Q1 2025 to a low of -$231.2 million in Q1 2025.